SG Americas Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-132,960
| Closed | -$35.9M | – | 2523 |
|
|
2025
Q1 | $35.9M | Buy |
132,960
+131,293
| +7,876% | +$35.5M | 0.12% | 113 |
|
|
2024
Q4 | $392K | Sell |
1,667
-1,723
| -51% | -$405K | ﹤0.01% | 1360 |
|
|
2024
Q3 | $932K | Buy |
3,390
+2,953
| +676% | +$812K | ﹤0.01% | 986 |
|
|
2024
Q2 | $106K | Sell |
437
-38,318
| -99% | -$9.29M | ﹤0.01% | 2210 |
|
|
2024
Q1 | $5.79M | Buy |
38,755
+38,095
| +5,772% | +$5.69M | 0.03% | 468 |
|
|
2023
Q4 | $126K | Sell |
660
-19,176
| -97% | -$3.66M | ﹤0.01% | 2340 |
|
|
2023
Q3 | $3.51M | Buy |
19,836
+16,025
| +420% | +$2.84M | 0.04% | 384 |
|
|
2023
Q2 | $724K | Sell |
3,811
-7,883
| -67% | -$1.5M | 0.01% | 1086 |
|
|
2023
Q1 | $2.34M | Buy |
11,694
+4,900
| +72% | +$982K | 0.03% | 520 |
|
|
2022
Q4 | $1.62M | Buy |
6,794
+5,575
| +457% | +$1.33M | 0.02% | 562 |
|
|
2022
Q3 | $244K | Sell |
1,219
-12,730
| -91% | -$2.55M | ﹤0.01% | 1919 |
|
|
2022
Q2 | $2.03M | Sell |
13,949
-14,065
| -50% | -$2.05M | 0.02% | 633 |
|
|
2022
Q1 | $4.57M | Buy |
28,014
+19,168
| +217% | +$3.13M | 0.03% | 388 |
|
|
2021
Q4 | $1.5M | Sell |
8,846
-2,041
| -19% | -$346K | 0.01% | 1220 |
|
|
2021
Q3 | $2.06M | Sell |
10,887
-8,185
| -43% | -$1.55M | 0.01% | 1128 |
|
|
2021
Q2 | $3.23M | Buy |
19,072
+16,386
| +610% | +$2.78M | 0.02% | 750 |
|
|
2021
Q1 | $379K | Buy |
2,686
+401
| +18% | +$56.6K | ﹤0.01% | 2002 |
|
|
2020
Q4 | $297K | Sell |
2,285
-919
| -29% | -$119K | ﹤0.01% | 2083 |
|
|
2020
Q3 | $467K | Sell |
3,204
-10,553
| -77% | -$1.54M | ﹤0.01% | 1399 |
|
|
2020
Q2 | $2.04M | Buy |
13,757
+10,015
| +268% | +$1.48M | 0.02% | 657 |
|
|
2020
Q1 | $407K | Buy |
3,742
+499
| +15% | +$54.3K | ﹤0.01% | 1652 |
|
|
2019
Q4 | $373K | Buy |
3,243
+1,470
| +83% | +$169K | ﹤0.01% | 1736 |
|
|
2019
Q3 | $143K | Buy |
+1,773
| New | +$143K | ﹤0.01% | 2174 |
|
|
2019
Q2 | – | Sell |
-133,828
| Closed | -$12.5M | – | 2519 |
|
|
2019
Q1 | $12.5M | Buy |
133,828
+114,143
| +580% | +$10.7M | 0.12% | 154 |
|
|
2018
Q4 | $1.44M | Buy |
19,685
+10,255
| +109% | +$748K | 0.01% | 939 |
|
|
2018
Q3 | $825K | Buy |
9,430
+4,652
| +97% | +$407K | 0.01% | 1635 |
|
|
2018
Q2 | $471K | Sell |
4,778
-18,108
| -79% | -$1.79M | ﹤0.01% | 1803 |
|
|
2018
Q1 | $2.73M | Buy |
+22,886
| New | +$2.73M | 0.02% | 608 |
|
|
2017
Q4 | – | Sell |
-1,538
| Closed | -$181K | – | 2518 |
|
|
2017
Q3 | $181K | Sell |
1,538
-105,643
| -99% | -$12.4M | ﹤0.01% | 2325 |
|
|
2017
Q2 | $8.55M | Buy |
+107,181
| New | +$8.55M | 0.08% | 226 |
|
|
2017
Q1 | – | Sell |
-22,683
| Closed | -$849K | – | 2776 |
|
|
2016
Q4 | $849K | Buy |
+22,683
| New | +$849K | 0.01% | 1275 |
|
|
2016
Q3 | – | Sell |
-6,353
| Closed | -$353K | – | 2820 |
|
|
2016
Q2 | $353K | Buy |
6,353
+1,510
| +31% | +$83.9K | ﹤0.01% | 1643 |
|
|
2016
Q1 | $304K | Buy |
4,843
+993
| +26% | +$62.3K | ﹤0.01% | 1764 |
|
|
2015
Q4 | $362K | Sell |
3,850
-2,439
| -39% | -$229K | ﹤0.01% | 1564 |
|
|
2015
Q3 | $505K | Sell |
6,289
-8,225
| -57% | -$660K | ﹤0.01% | 1066 |
|
|
2015
Q2 | $1.74M | Buy |
14,514
+10,165
| +234% | +$1.22M | 0.01% | 702 |
|
|
2015
Q1 | $454K | Sell |
4,349
-12,497
| -74% | -$1.3M | ﹤0.01% | 1325 |
|
|
2014
Q4 | $1.63M | Buy |
+16,846
| New | +$1.63M | 0.01% | 938 |
|
|
2014
Q2 | – | Sell |
-7,836
| Closed | -$526K | – | 2076 |
|
|
2014
Q1 | $526K | Buy |
+7,836
| New | +$526K | ﹤0.01% | 1315 |
|
|
2013
Q4 | – | Sell |
-10,971
| Closed | -$702K | – | 2160 |
|
|
2013
Q3 | $702K | Buy |
+10,971
| New | +$702K | ﹤0.01% | 1301 |
|